Welcome to our dedicated page for Performant Finl SEC filings (Ticker: PHLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The PHLT SEC filings page on Stock Titan provides access to historical regulatory documents for Performant Healthcare, Inc., which operated as a public company on Nasdaq before being acquired and taken private. These filings, drawn from the SEC’s EDGAR system, show how Performant reported on its healthcare payment integrity, eligibility, and analytics services business to investors and regulators.
Key filings include Form 10‑K annual reports and Form 10‑Q quarterly reports, where Performant discusses its role in helping healthcare payers identify, prevent, and recover waste and improper payments. In these reports and related exhibits, the company explains its eligibility-based (coordination-of-benefits) and claims-based services, its use of advanced technology, analytics, and proprietary data assets, and the balance of activity between government and commercial healthcare markets.
The page also features multiple Form 8‑K current reports that capture significant events. For example, a June 2025 Form 8‑K details voting results from the 2025 Annual Meeting of Stockholders. An August 1, 2025 Form 8‑K describes the Agreement and Plan of Merger with Continental Buyer, Inc. and Prevail Merger Sub, Inc., including the planned cash consideration for each share of common stock and the treatment of equity awards. Another August 1, 2025 Form 8‑K furnishes preliminary financial results for the quarter ended June 30, 2025 via an attached press release.
A pivotal Form 8‑K dated October 17, 2025 reports that stockholders approved the merger agreement at a special meeting. A subsequent Form 8‑K dated October 21, 2025 documents the completion of the merger, the conversion of outstanding shares into the right to receive cash consideration, the resulting change in control, and the steps to delist and deregister the PHLT shares, including a request for Nasdaq to file Form 25 and the company’s intention to file Form 15.
On Stock Titan, these filings are presented with AI-powered summaries that highlight the most important points from lengthy documents, helping users quickly understand topics such as revenue composition, non‑GAAP measures like adjusted EBITDA, and the legal and financial terms of the merger. Real-time updates from EDGAR ensure that all historical 8‑K, 10‑K, and 10‑Q filings for PHLT are captured, while Form 4 and other ownership-related filings can be used to review historical insider activity prior to the company’s transition to private ownership.
On 28 Jul 2025, Performant Healthcare (PHLT) filed a Form 4 indicating that director William D. Hansen was granted 35,616 restricted stock units (RSUs) at no cost. Each RSU converts into one share of common stock and will vest 100% on the earlier of the company’s 2026 annual shareholder meeting or a Change in Control, after which settlement must be in stock. Following the award, Hansen beneficially owns 35,616 derivative securities, all held directly. Table I shows no open-market purchases or sales of common shares.
- No cash consideration—pure equity incentive.
- Filing involves one reporting person; Hansen remains a director, not a 10 % owner.
On June 18, 2025, Performant Healthcare, Inc. (Nasdaq: PHLT) held its 2025 Annual Meeting of Stockholders with an 86.58% quorum (67,801,465 shares present or represented). The meeting covered two routine governance items:
- Election of three Class I directors—James LaCamp, Shantanu Agrawal, and Simeon M. Kohl—each received at least 93.7% of votes cast for, ensuring board continuity through the 2028 Annual Meeting.
- Ratification of independent auditor—Baker Tilly US, LLP was confirmed for the fiscal year ending December 31, 2025 with 99.96% shareholder support (65,621,257 for; 13,650 against; 2,166,558 abstain).
No other business, financial results, or strategic actions were disclosed. The filing is limited to Item 5.07 voting results and does not signal any material operational or financial change.